$AREB
AMERICAN REBEL HOLDINGS INC Stock $areb

$areb Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000149315222031515 Filed on November 14, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$3.854M	$4.103M	$295.5K
YoY Change	2683.45%	1288.46%	5.79%
Cost Of Revenue	$3.047M	$3.125M	$280.2K
YoY Change	3100.89%	1015.11%	22.59%
Gross Profit	$807.3K	$978.1K	$15.28K
YoY Change	1765.34%	6301.2%	-69.88%
Gross Profit Margin	20.95%	23.84%	5.17%
Selling, General & Admin	$759.9K	$2.619M	$893.6K
YoY Change	25.93%	193.13%	111.03%
% of Gross Profit	94.12%	267.79%	5847.84%
Research & Development	$758.6K		$77.39K
YoY Change	773.73%		-56.98%
% of Gross Profit	93.96%		506.48%
Depreciation & Amortization	$38.78K	$9.950K	$1.360K
YoY Change	7979.17%	631.62%	-91.23%
% of Gross Profit	4.8%	1.02%	8.9%
Operating Expenses	$1.557M	$2.748M	$971.9K
YoY Change	125.32%	182.79%	57.06%
Operating Profit	-$749.9K	-$1.770M	-$956.6K
YoY Change	15.75%	85.06%	68.39%
Interest Expense	-$15.55K	$31.58K	-$382.6K
YoY Change	-97.23%	-108.26%	-43.82%
% of Operating Profit
Other Income/Expense, Net		-$377.2K	-$470.2K
YoY Change		-19.78%
Pretax Income	-$765.4K	-$2.147M	-$1.427M
YoY Change	-36.68%	50.51%	8.25%
Income Tax	$0.00
% Of Pretax Income
Net Earnings	-$765.4K	-$2.147M	-$1.427M
YoY Change	-36.68%	50.51%	8.25%
Net Earnings / Revenue	-19.86%	-52.34%	-482.85%
Basic Earnings Per Share		-$0.36	-$1.05
Diluted Earnings Per Share	-$0.05	-$356.0K	-$1.053M
COMMON SHARES
Basic Shares Outstanding	16.55M shares	5.251M shares	1.355M shares
Diluted Shares Outstanding		241.3K shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$356.8K	$1.186M	$218.3K
YoY Change	1925.84%	443.02%	31.62%
Cash & Equivalents	$356.8K	$1.186M	$218.3K
Short-Term Investments
Other Short-Term Assets	$207.1K	$147.8K	$163.5K
YoY Change	26.64%	-9.58%	61.47%
Inventory	$7.731M	$6.537M	$764.5K
Prepaid Expenses	$207.1K	$147.8K
Receivables	$1.613M	$2.446M	$179.2K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$9.909M	$10.32M	$1.326M
YoY Change	923.94%	678.25%	-3.56%
LONG-TERM ASSETS
Property, Plant & Equipment	$456.5K	$486.1K	$1.800K
YoY Change	50625.0%	26903.89%	-91.21%
Goodwill	$4.200M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$6.195M	$4.220M
YoY Change
Total Long-Term Assets	$6.652M	$4.706M	$1.800K
YoY Change	738998.44%	261327.94%	-93.41%
TOTAL ASSETS
Total Short-Term Assets	$9.909M	$10.32M	$1.326M
Total Long-Term Assets	$6.652M	$4.706M	$1.800K
Total Assets	$16.56M	$15.02M	$1.327M
YoY Change	1609.74%	1031.71%	-5.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.524M	$2.312M	$739.8K
YoY Change	144.47%	212.53%	17.42%
Accrued Expenses	$1.096M	$67.92K	$287.6K
YoY Change	437.54%	-76.39%	-52.22%
Deferred Revenue
YoY Change
Short-Term Debt	$602.6K	$603.8K	$3.637M
YoY Change	-84.47%	-83.4%	-15.48%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.223M	$2.988M	$4.664M
YoY Change	-17.83%	-35.94%	-15.73%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$984.8K
YoY Change
Total Long-Term Liabilities	$984.8K	$0.00	$0.00
YoY Change			-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.223M	$2.988M	$4.664M
Total Long-Term Liabilities	$984.8K	$0.00	$0.00
Total Liabilities	$5.207M	$2.988M	$4.664M
YoY Change	1.33%	-35.94%	-19.72%
SHAREHOLDERS EQUITY
Retained Earnings	-$34.11M	-$33.35M
YoY Change	26.49%
Common Stock	$16.93K	$8.474K
YoY Change	960.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$11.35M	$12.03M	-$3.337M
YoY Change
Total Liabilities & Shareholders Equity	$16.56M	$15.02M	$1.327M
YoY Change	1609.74%	1031.71%	-5.31%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$765.4K	-$2.147M	-$1.427M
YoY Change	-36.68%	50.51%	8.25%
Depreciation, Depletion And Amortization	$38.78K	$9.950K	$1.360K
YoY Change	7979.17%	631.62%	-91.23%
Cash From Operating Activities	-$900.8K	-$2.024M	-$608.0K
YoY Change	-711.17%	232.81%	-1095.25%
INVESTING ACTIVITIES
Capital Expenditures	$7.240K	$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$10.25M	$0.00
YoY Change
Cash From Investing Activities	-$7.240K	-$10.25M	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	79.21K	10.95M	559.0K
YoY Change	-123.25%	1858.38%	-357.47%
NET CHANGE
Cash From Operating Activities	-900.8K	-2.024M	-608.0K
Cash From Investing Activities	-7.240K	-10.25M	0.000
Cash From Financing Activities	79.21K	10.95M	559.0K
Net Change In Cash	-828.8K	-1.324M	-49.04K
YoY Change	328.74%	2600.63%	-68.57%
FREE CASH FLOW
Cash From Operating Activities	-$900.8K	-$2.024M	-$608.0K
Capital Expenditures	$7.240K	$0.00
Free Cash Flow	-$908.0K	-$2.024M
YoY Change	-716.09%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001648087
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess		usd
CY2021Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill		usd
CY2021Q4	us-gaap	Deposit Assets DepositAssets		usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent		usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	848357	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2022Q3	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent		usd
CY2022Q3	us-gaap	Other Long Term Debt OtherLongTermDebt		usd
CY2021Q4	us-gaap	Other Long Term Debt OtherLongTermDebt		usd
CY2021Q3	AREB	Rental Expense Warehousing Outlet Expense RentalExpenseWarehousingOutletExpense		usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense		usd
CY2021Q3	AREB	Interest Expense Preemptive Rights Release InterestExpensePreemptiveRightsRelease		usd
CY2021Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest		usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	AREB	Rental Expense Warehousing Outlet Expense RentalExpenseWarehousingOutletExpense		usd
	AREB	Interest Expense Preemptive Rights Release InterestExpensePreemptiveRightsRelease		usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Payments To Acquire Business Two Net Of Cash Acquired PaymentsToAcquireBusinessTwoNetOfCashAcquired		usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants		usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2021Q4	us-gaap	Inventory For Long Term Contracts Or Programs InventoryForLongTermContractsOrPrograms		usd
CY2022Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2020Q4	AREB	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue		usd
CY2021	AREB	Share Based Compensation Arrangement By Share Based Payment Award Non Options Grants In Period Grant Date Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantsInPeriodGrantDateIntrinsicValue
CY2021	AREB	Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisesInPeriodTotalIntrinsicValue		usd
CY2021	AREB	Share Based Compensation Arrangements By Share Based Payment Award Non Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2021	AREB	Share Based Compensation Arrangement By Share Based Payment Award Non Options Expired In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExpiredInPeriodTotalIntrinsicValue		usd
CY2021Q4	AREB	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue		usd
	AREB	Share Based Compensation Arrangement By Share Based Payment Award Non Options Grants In Period Grant Date Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantsInPeriodGrantDateIntrinsicValue
	AREB	Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisesInPeriodTotalIntrinsicValue		usd
	AREB	Share Based Compensation Arrangements By Share Based Payment Award Non Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExpirationsInPeriodWeightedAverageExercisePrice
	AREB	Share Based Compensation Arrangement By Share Based Payment Award Non Options Expired In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExpiredInPeriodTotalIntrinsicValue		usd
CY2022Q3	AREB	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41267
	dei	Entity Registrant Name EntityRegistrantName	AMERICAN REBEL HOLDINGS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-3892903
	dei	Entity Address Address Line1 EntityAddressAddressLine1	909 18th Avenue South
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite A
	dei	Entity Address City Or Town EntityAddressCityOrTown	Nashville
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TN
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	37212
	dei	City Area Code CityAreaCode	(833)
	dei	Local Phone Number LocalPhoneNumber	267-3235
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Trading Symbol TradingSymbol	AREB
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	16553033	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1185578	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17607	usd
CY2022Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	2446290	usd
CY2021Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	100746	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	147832	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	163492	usd
CY2022Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	6306341	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	685854	usd
CY2022Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	230223	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	10316264	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	967699	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	486070	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	900	usd
CY2022Q3	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	4200000	usd
CY2022Q3	us-gaap	Deposit Assets DepositAssets	19633	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4219633	usd
CY2022Q3	us-gaap	Assets Assets	15021967	usd
CY2021Q4	us-gaap	Assets Assets	968599	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2312081	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1032264	usd
CY2022Q3	us-gaap	Interest Payable Current InterestPayableCurrent	67919	usd
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	203972	usd
CY2021Q4	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	10373	usd
CY2022Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	603840	usd
CY2021Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	3879428	usd
CY2022Q3	us-gaap	Loans Payable To Bank Current LoansPayableToBankCurrent	4152	usd
CY2021Q4	us-gaap	Loans Payable To Bank Current LoansPayableToBankCurrent	12939	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2987992	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5138976	usd
CY2022Q3	us-gaap	Liabilities Liabilities	2987992	usd
CY2021Q4	us-gaap	Liabilities Liabilities	5138976	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8474033	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8474033	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1597370	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1597370	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	8474	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	1597	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	45372714	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	22797306	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-33347388	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26969657	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	12033975	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-4170377	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15021967	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	968599	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4102761	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	295490	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	3124657	usd
CY2021Q3	us-gaap	Cost Of Revenue CostOfRevenue	280212	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	978104	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	15278	usd
CY2022Q3	AREB	Consulting Payroll And Other Payroll Costs ConsultingPayrollAndOtherPayrollCosts	1227953	usd
CY2021Q3	AREB	Consulting Payroll And Other Payroll Costs ConsultingPayrollAndOtherPayrollCosts	656784	usd
CY2022Q3	AREB	Rental Expense Warehousing Outlet Expense RentalExpenseWarehousingOutletExpense	314314	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	42720	usd
CY2022Q3	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	119122	usd
CY2021Q3	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	34669	usd
CY2022Q3	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1077005	usd
CY2021Q3	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	236763	usd
CY2022Q3	us-gaap	Depreciation Nonproduction DepreciationNonproduction	9956	usd
CY2021Q3	us-gaap	Depreciation Nonproduction DepreciationNonproduction	946	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	2748350	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	971882	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1770246	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-956604	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	31584	usd
CY2021Q3	us-gaap	Interest Expense InterestExpense	382601	usd
CY2022Q3	AREB	Interest Expense Preemptive Rights Release InterestExpensePreemptiveRightsRelease	350000	usd
CY2022Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	4428	usd
CY2021Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-87575	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-377156	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-470176	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2147402	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1426780	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2147402	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-1426780	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.36
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.05
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6031715	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1354700	shares
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4595547	usd
	us-gaap	Cost Of Revenue CostOfRevenue	3462454	usd
	us-gaap	Cost Of Revenue CostOfRevenue	716943	usd
	us-gaap	Gross Profit GrossProfit	1133093	usd
	us-gaap	Gross Profit GrossProfit	131414	usd
	AREB	Consulting Payroll And Other Payroll Costs ConsultingPayrollAndOtherPayrollCosts	1937349	usd
	AREB	Consulting Payroll And Other Payroll Costs ConsultingPayrollAndOtherPayrollCosts	1774003	usd
	AREB	Rental Expense Warehousing Outlet Expense RentalExpenseWarehousingOutletExpense	314314	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	146463	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	275780	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	349341	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	138783	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	2687728	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	603727	usd
	us-gaap	Depreciation Nonproduction DepreciationNonproduction	11311	usd
	us-gaap	Depreciation Nonproduction DepreciationNonproduction	2744	usd
	us-gaap	Operating Expenses OperatingExpenses	5446506	usd
	us-gaap	Operating Expenses OperatingExpenses	2795037	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4313413	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2663623	usd
	us-gaap	Interest Expense InterestExpense	341990	usd
	us-gaap	Interest Expense InterestExpense	1500744	usd
	AREB	Interest Expense Preemptive Rights Release InterestExpensePreemptiveRightsRelease	350000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	4428	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1376756	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-725723	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2064318	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2226467	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6377731	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4890090	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6377731	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4890090	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.34
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.23
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4743244	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1155513	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-5012437	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	150000	usd
	AREB	Stock Issued During Period Of Common Stock Issued To Pay Expense StockIssuedDuringPeriodOfCommonStockIssuedToPayExpense	105466	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4890090	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-5684586	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-4170377	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-4170377	usd
	AREB	Stock Issued During Period Value New Issues1 StockIssuedDuringPeriodValueNewIssues1	9038456	usd
	AREB	Stock Issued During Period Of Common Stock Issued To Pay Expense StockIssuedDuringPeriodOfCommonStockIssuedToPayExpense	969535	usd
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	1566559	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	565335	usd
CY2022Q3	AREB	Sale Of Prefunded Stock Price Per Share SaleOfPrefundedStockPricePerShare	1.10
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.01
	AREB	Adjustments To Additional Paid In Capital Sale Of Prefunded Common Stock Warrants AdjustmentsToAdditionalPaidInCapitalSaleOfPrefundedCommonStockWarrants	12322542	usd
	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-1972578	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	61000	usd
	AREB	Stock Issued During Period Exercise Of Prefunded Warrants Value StockIssuedDuringPeriodExerciseOfPrefundedWarrantsValue	31234	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6377731	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	12033975	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	12033975	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6377731	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4890090	usd
	us-gaap	Depreciation Depreciation	11311	usd
	us-gaap	Depreciation Depreciation	3158	usd
	us-gaap	Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash	1030535	usd
	us-gaap	Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash	2806826	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	1000457	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	839434	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	219697	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6830	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-20184	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	8010	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	869985	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6120	usd
	AREB	Increase Decrease In Inventory Deposits IncreaseDecreaseInInventoryDeposits	224894	usd
	AREB	Increase Decrease In Inventory Deposits IncreaseDecreaseInInventoryDeposits	-64479	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-297513	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	201915	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5927333	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-995238	usd
	us-gaap	Payments To Acquire Business Two Net Of Cash Acquired PaymentsToAcquireBusinessTwoNetOfCashAcquired	10247420	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	13651	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10261071	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-81506	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	14658	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	9603791	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	697505	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	10349964	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	31234	usd
	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	60000	usd
	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	2169100	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	2607108	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	1736000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	17356375	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1145263	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1167971	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	150025	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	17607	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	68307	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1185578	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	218332	usd
	us-gaap	Interest Paid Net InterestPaidNet	234146	usd
	us-gaap	Interest Paid Net InterestPaidNet	176910	usd
	AREB	Debt Repayment Through Issuance Of Common Stock DebtRepaymentThroughIssuanceOfCommonStock	2011224	usd
	AREB	Debt Repayment Through Issuance Of Common Stock DebtRepaymentThroughIssuanceOfCommonStock	1713924	usd
	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2014-12-15
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	us-gaap	Fiscal Period FiscalPeriod	<p id="xdx_84B_eus-gaap--FiscalPeriod_zNQrBB8WfW44" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86D_zU9AQJkPqDLl">Year end</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s year-end is December 31.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q3	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	119122	usd
CY2021Q3	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	34669	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	349341	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	138783	usd
CY2016Q4	us-gaap	Loans Payable LoansPayable	277886	usd
	us-gaap	Income Tax Examination Description IncomeTaxExaminationDescription	less than a 50% likelihood
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_847_eus-gaap--UseOfEstimates_zHBVFBm8S4fh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86D_zZTwT1OALXL4">Use of estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Net Income Loss NetIncomeLoss	-6377731	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4890090	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-33347388	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26969657	usd
CY2022Q3	AREB	Working Capital Deficit WorkingCapitalDeficit	7328272	usd
CY2021Q4	AREB	Working Capital Deficit WorkingCapitalDeficit	-4171277	usd
CY2022Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	6306341	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	685854	usd
CY2022Q3	us-gaap	Inventory For Long Term Contracts Or Programs InventoryForLongTermContractsOrPrograms	230223	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	6536564	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	685854	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2627815	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	310147	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2141745	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	309247	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	486070	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	900	usd
	us-gaap	Depreciation Depreciation	11311	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2744	usd
CY2022Q3	us-gaap	Loans Payable To Bank Current LoansPayableToBankCurrent	4152	usd
CY2021Q4	us-gaap	Loans Payable To Bank Current LoansPayableToBankCurrent	12939	usd
CY2022Q3	us-gaap	Secured Debt SecuredDebt	603840	usd
CY2021Q4	us-gaap	Secured Debt SecuredDebt	3879428	usd
CY2022Q3	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	33347388	usd
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	26969657	usd
CY2022Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	7002951	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5663628	usd
CY2022Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	7002951	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	5663628	usd
CY2022Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7002951	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5663628	usd
CY2022Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7002951	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5663628	usd
	us-gaap	Valuation Allowance Deferred Tax Asset Explanation Of Change ValuationAllowanceDeferredTaxAssetExplanationOfChange	As a result, management determined it was more likely than not deferred tax assets will not be realized as of September 30, 2022, and December 31, 2021, and recognized 100% valuation allowance for each period
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	2909639	shares
	AREB	Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice	5.1875
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.000	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.210	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	On February 7, 2022, the Company effectuated a reverse split of its issued and outstanding shares of common stock at a ratio of 1-for-80. The share numbers and pricing information in this report are adjusted to reflect the reverse stock split
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8474033	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8474033	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1597370	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1597370	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	35867869	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	701776	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	43688	shares
CY2020Q4	AREB	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	20.80
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y5M23D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	662713	shares
CY2021	AREB	Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice	8.00
CY2021	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2	P2Y11M12D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations	4625	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	701776	shares
CY2021Q4	AREB	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	8.80
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y11M12D
	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2	P5Y
	AREB	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted In Debt Conversion ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedInDebtConversion	377484	shares
	AREB	Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Debt Conversion Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInDebtConversionWeightedAverageExercisePrice	5.1875
	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted In Debt Conversion Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedInDebtConversionWeightedAverageRemainingContractualTerm2	P5Y
	AREB	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted Prefunded Warrants ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedPrefundedWarrants	11579885	shares
	AREB	Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants Prefunded Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsPrefundedWeightedAverageExercisePrice	0.01
	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Prefunded Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedPrefundedWeightedAverageRemainingContractualTerm2	P5Y
	AREB	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted In Private Investment In Public Equity ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedInPrivateInvestmentInPublicEquity	23423424	shares
	AREB	Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants Private Investment In Public Equity Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsPrivateInvestmentInPublicEquityWeightedAverageExercisePrice	0.86
	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Private Investment In Public Equity Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedPrivateInvestmentInPublicEquityWeightedAverageRemainingContractualTerm2	P5Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	3123401	shares
	AREB	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercised In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice	0.01
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations	938	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	35867869	shares
CY2022Q3	AREB	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	1.22
	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term3 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3	P4Y11M1D
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	294794	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	985956	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	610623	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	85891	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	43316	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	3733	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2024313	usd
	us-gaap	Payments For Rent PaymentsForRent	300000	usd
	us-gaap	Payments For Rent PaymentsForRent	100000	usd

Files In Submission

Name	View Source	Status
areb-20220930_def.xml	Edgar Link	unprocessable
0001493152-22-031515-index-headers.html	Edgar Link	pending
0001493152-22-031515-index.html	Edgar Link	pending
0001493152-22-031515.txt	Edgar Link	pending
0001493152-22-031515-xbrl.zip	Edgar Link	pending
areb-20220930.xsd	Edgar Link	pending
areb-20220930_cal.xml	Edgar Link	unprocessable
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
areb-20220930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
areb-20220930_lab.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AREB
AMERICAN REBEL HOLDINGS INC Stock $areb

2022 Q4 Form 10-Q Financial Statement

#000149315222031515 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AREB AMERICAN REBEL HOLDINGS INC Stock $areb

2022 Q4 Form 10-Q Financial Statement

#000149315222031515 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AREB
AMERICAN REBEL HOLDINGS INC Stock $areb